Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Helene Damhofer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-4459-7534; OpenAlex author ID A5059942902. Sources: OpenAlex.

Their work

Papers
9 (first author 4, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: 1 paper · 2016: none · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 9

  1. Stromal Hedgehog Signaling Is Associated with Favorable Outcomes in Pancreatic Cancer. First author DOI 10.3390/ijms26115200↗
  2. EZH2i unlocks PDAC immune surveillance. Co-author DOI 10.1038/s43018-023-00562-7↗
  3. Unsupervised class discovery in pancreatic ductal adenocarcinoma reveals cell-intrinsic mesenchymal features and high concordance between existing classificati… Co-author DOI 10.1038/s41598-019-56826-9↗
  4. ADAM12 is a circulating marker for stromal activation in pancreatic cancer and predicts response to chemotherapy. First author DOI 10.1038/s41389-018-0096-9↗
  5. Stromal SPOCK1 supports invasive pancreatic cancer growth. First author DOI 10.1002/1878-0261.12073↗
  6. Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice. First author DOI 10.2119/molmed.2016.00214↗
  7. Blocking Hedgehog release from pancreatic cancer cells increases paracrine signaling potency. Co-author DOI 10.1242/jcs.157966↗
  8. Assessment of the stromal contribution to Sonic Hedgehog-dependent pancreatic adenocarcinoma. Co-author DOI 10.1016/j.molonc.2013.08.004↗
  9. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. Co-author DOI 10.1002/emmm.201100201↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maarten F. Bijlsma · 6 shared papers, 2013–2025 · strength 0.64
  2. Hanneke W.M. van Laarhoven · 5 shared papers, 2015–2025 · strength 0.60
  3. Lan Zhao · 2 shared papers, 2020–2025 · strength 0.41
  4. Kristian Helin · 1 shared paper, 2023 · strength 0.39
  5. Paul Manoukian · 1 shared paper, 2025 · strength 0.33
  6. Veronique L. Veenstra · 5 shared papers, 2013–2020 · strength 0.31
  7. Anne Steins · 2 shared papers, 2017–2020 · strength 0.15
  8. L. Bengt van Rijssen · 2 shared papers, 2018–2020 · strength 0.14
  9. Hanneke W. Wilmink · 2 shared papers, 2018–2020 · strength 0.14
  10. Frederike Dijk · 2 shared papers, 2018–2020 · strength 0.14
  11. Marc G. Besselink · 2 shared papers, 2018–2020 · strength 0.14
  12. Johanna A.M.G. Tol · 2 shared papers, 2015–2020 · strength 0.14
  13. Hemant Mahendrakumar Kocher · 2 shared papers, 2017–2018 · strength 0.14
  14. Dick J. Richel · 1 shared paper, 2017 · strength 0.08
  15. C. Arnold Spek · 1 shared paper, 2017 · strength 0.08
  16. Kun Shi · 1 shared paper, 2017 · strength 0.08
  17. Mark P.G. Dings · 1 shared paper, 2020 · strength 0.08
  18. Sjors Klompmaker · 1 shared paper, 2020 · strength 0.08
  19. Xin Wang · 1 shared paper, 2020 · strength 0.08
  20. Louis Vermeulen · 1 shared paper, 2020 · strength 0.08
  21. Eline C. Soer · 1 shared paper, 2020 · strength 0.08
  22. Joanne Verheij · 1 shared paper, 2020 · strength 0.08
  23. Peter J. Bailey · 1 shared paper, 2018 · strength 0.06
  24. David Kuang-Fu Chang · 1 shared paper, 2018 · strength 0.06
  25. Andrew Victor Biankin · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.